News
hna Foundation awards a project led by Dr. Povedano on biomarkers for the detection of ALS
Yesterday was the award ceremony of the fourth edition of the hna Foundation’s Scientific Health Research Awards, which this year has focused on Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease with no cure and few diagnostic tools.
IDIBELL, reaccredited as Instituto de Investigación Sanitaria by the Instituto de Salud Carlos III
This recognition, which must be renewed every five years, allows the Institute to access various sources of funding offered by the Ministry of Health.
The VIII Barcelona Fire Brigade Solidarity Nautical Mile 2024 will support research into the rare disease LAM
This is the VIII edition of the Barcelona Firefighters Solidarity Nautical Mile, which will be held on Sunday, June 30 on Bogatell beach (Barcelona).
Virginia Nunes, head of the Human Molecular Genetics group and one of the founders of IDIBELL, passes away
Virginia Nunes, pioneer of human genetics and coordinator of the Genes, Disease and Therapy Program at the Bellvitge Biomedical Research Institute (IDIBELL), passed away on May 24, 2024, after a long disease.
The Pinnae Foundation organizes a charity dinner to support ALS research
The dinner features the collaboration of renowned chefs, and will also include live musical accompaniment and other activities.
Two nurses from Bellvitge receive the Young Talent Award from the Catalano-Balearic Nursing Society
The predoctoral researcher from IDIBELL and the Bellvitge Hospital Andrea Urbina receives the award in the Research category.
A study published in ‘The Lancet’ evaluates the impact of surgery on severe haemorrhagic stroke
A European study led at a national level by neurosurgeons from the Bellvitge University Hospital and IDIBELL has provided relevant new knowledge on the impact of surgery on the prognosis and recovery of patients with severe haemorrhagic stroke.
New advance in viral cancer immunotherapy
Researchers from IDIBELL, UB and the LMU of Munich discover a viral strain capable of inducing immunogenic cell death in tumor cells. The virus described is effective in the treatment of tumors such as melanoma, colon or renal cancer.
M. Carolina Florian: pioneering stem-cell researcher featured in Nature
The ICREA Research Professor at IDIBELL recently demonstrated how to “hack” the immune system to slow down aging.